| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 69.83B | 67.47B | 61.84B | 54.61B | 44.61B | 38.25B |
| Gross Profit | 40.44B | 40.22B | 36.40B | 31.06B | 25.65B | 22.63B |
| EBITDA | 7.27B | 8.71B | 6.94B | 3.75B | 2.21B | 1.44B |
| Net Income | 4.72B | 4.96B | 3.26B | 1.01B | 1.30B | -443.06M |
Balance Sheet | ||||||
| Total Assets | 40.79B | 35.01B | 32.92B | 30.85B | 27.00B | 24.36B |
| Cash, Cash Equivalents and Short-Term Investments | 6.65B | 11.95B | 10.55B | 7.69B | 7.00B | 5.26B |
| Total Debt | 10.68B | 8.20B | 10.12B | 12.38B | 11.15B | 10.36B |
| Total Liabilities | 21.58B | 17.95B | 19.38B | 20.55B | 17.69B | 16.26B |
| Stockholders Equity | 19.21B | 17.06B | 13.54B | 10.30B | 9.30B | 8.10B |
Cash Flow | ||||||
| Free Cash Flow | 1.40B | 4.92B | 5.12B | 2.84B | 2.81B | 218.40M |
| Operating Cash Flow | 3.65B | 6.79B | 6.22B | 4.68B | 4.03B | 1.60B |
| Investing Cash Flow | -4.21B | -1.77B | -906.26M | -2.19B | -1.85B | -2.08B |
| Financing Cash Flow | -3.35B | -3.58B | -2.60B | -1.86B | -509.25M | 2.22B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ¥142.38B | 56.48 | ― | 1.71% | 9.51% | 6.29% | |
70 Outperform | ¥131.97B | 20.09 | ― | 0.70% | 5.15% | 47.13% | |
64 Neutral | ¥49.89B | 11.04 | ― | 2.41% | 6.49% | 4.27% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥222.07B | 42.91 | ― | 0.69% | 10.75% | -14.28% | |
58 Neutral | ¥141.18B | 31.47 | ― | 0.63% | 4.32% | 11.78% | |
56 Neutral | ¥78.05B | -50.43 | ― | 0.32% | 0.51% | 4.92% |